Bernhard Kölbl

Title: Bernhard Kölbl: Innovator in Immunoglobulin Stabilization

Introduction

Bernhard Kölbl is a notable inventor based in Achau, Austria. He has made significant contributions to the field of immunology, particularly in the stabilization of immunoglobulin formulations. With a total of three patents to his name, Kölbl's work has the potential to impact medical treatments involving immunoglobulins.

Latest Patents

Kölbl's latest patents include innovative methods for stabilizing immunoglobulins. One of his patents focuses on the "Stabilization of immunoglobulins through aqueous formulation with histidine at weak acidic to neutral pH." This invention provides storage-stable aqueous formulations of immunoglobulins, which are useful for parenteral administration. Another significant patent is the "Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition." This invention outlines methods for reducing the amidolytic and anti-complement activity content of immunoglobulin compositions, enhancing their safety and efficacy.

Career Highlights

Throughout his career, Kölbl has worked with prominent companies in the biopharmaceutical industry, including Baxalta GmbH and Baxter International Inc. His experience in these organizations has contributed to his expertise in immunoglobulin research and development.

Collaborations

Kölbl has collaborated with notable colleagues such as Harald Arno Butterweck and Lucia Hofbauer. These collaborations have likely enriched his research and contributed to the advancements in his field.

Conclusion

Bernhard Kölbl's innovative work in the stabilization of immunoglobulins showcases his commitment to improving medical treatments. His patents reflect a deep understanding of immunology and a dedication to enhancing patient care.